198 related articles for article (PubMed ID: 23264338)
1. Risk of mortality in patients with psoriatic arthritis, rheumatoid arthritis and psoriasis: a longitudinal cohort study.
Ogdie A; Haynes K; Troxel AB; Love TJ; Hennessy S; Choi H; Gelfand JM
Ann Rheum Dis; 2014 Jan; 73(1):149-53. PubMed ID: 23264338
[TBL] [Abstract][Full Text] [Related]
2. Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study.
Ogdie A; Yu Y; Haynes K; Love TJ; Maliha S; Jiang Y; Troxel AB; Hennessy S; Kimmel SE; Margolis DJ; Choi H; Mehta NN; Gelfand JM
Ann Rheum Dis; 2015 Feb; 74(2):326-32. PubMed ID: 25351522
[TBL] [Abstract][Full Text] [Related]
3. Risk of venous thromboembolism in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a general population-based cohort study.
Ogdie A; Kay McGill N; Shin DB; Takeshita J; Jon Love T; Noe MH; Chiesa Fuxench ZC; Choi HK; Mehta NN; Gelfand JM
Eur Heart J; 2018 Oct; 39(39):3608-3614. PubMed ID: 28444172
[TBL] [Abstract][Full Text] [Related]
4. Cause-specific mortality in patients with psoriatic arthritis and rheumatoid arthritis.
Ogdie A; Maliha S; Shin D; Love TJ; Baker J; Jiang Y; Choi H; Gelfand JM
Rheumatology (Oxford); 2017 Jun; 56(6):907-911. PubMed ID: 28158384
[TBL] [Abstract][Full Text] [Related]
5. Physical trauma recorded in primary care is associated with the onset of psoriatic arthritis among patients with psoriasis.
Thorarensen SM; Lu N; Ogdie A; Gelfand JM; Choi HK; Love TJ
Ann Rheum Dis; 2017 Mar; 76(3):521-525. PubMed ID: 27457510
[TBL] [Abstract][Full Text] [Related]
6. Incidence and Management of Cardiovascular Risk Factors in Psoriatic Arthritis and Rheumatoid Arthritis: A Population-Based Study.
Jafri K; Bartels CM; Shin D; Gelfand JM; Ogdie A
Arthritis Care Res (Hoboken); 2017 Jan; 69(1):51-57. PubMed ID: 27696731
[TBL] [Abstract][Full Text] [Related]
7. Subsequent Cardiovascular Events Among Patients With Rheumatoid Arthritis, Psoriatic Arthritis, or Psoriasis: Patterns of Disease-Modifying Antirheumatic Drug Treatment.
Sparks JA; Lesperance T; Accortt NA; Solomon DH
Arthritis Care Res (Hoboken); 2019 Apr; 71(4):512-520. PubMed ID: 29799667
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular risk factors predicting cardiac events are different in patients with rheumatoid arthritis, psoriatic arthritis, and psoriasis.
Cooksey R; Brophy S; Kennedy J; Gutierrez FF; Pickles T; Davies R; Piguet V; Choy E
Semin Arthritis Rheum; 2018 Dec; 48(3):367-373. PubMed ID: 29656791
[TBL] [Abstract][Full Text] [Related]
9. The Risk of Mortality among Psoriatic Patients with Varying Severity: A Nationwide Population-Based Cohort Study in Taiwan.
Dai YX; Hsu MC; Hu HY; Chang YT; Chen TJ; Li CP; Wu CY
Int J Environ Res Public Health; 2018 Nov; 15(12):. PubMed ID: 30467301
[No Abstract] [Full Text] [Related]
10. Diabetes incidence in psoriatic arthritis, psoriasis and rheumatoid arthritis: a UK population-based cohort study.
Dubreuil M; Rho YH; Man A; Zhu Y; Zhang Y; Love TJ; Ogdie A; Gelfand JM; Choi HK
Rheumatology (Oxford); 2014 Feb; 53(2):346-52. PubMed ID: 24185762
[TBL] [Abstract][Full Text] [Related]
11. Biological disease-modifying antirheumatic drugs may mitigate the risk of psoriatic arthritis in patients with chronic plaque psoriasis.
Gisondi P; Bellinato F; Targher G; Idolazzi L; Girolomoni G
Ann Rheum Dis; 2022 Jan; 81(1):68-73. PubMed ID: 34144965
[TBL] [Abstract][Full Text] [Related]
12. Serious infections in patients with rheumatoid arthritis and psoriatic arthritis treated with tumour necrosis factor inhibitors: data from register linkage of the NOR-DMARD study.
Christensen IE; Lillegraven S; Mielnik P; Bakland G; Loli L; Sexton J; Uhlig T; Kvien TK; Provan SA
Ann Rheum Dis; 2022 Mar; 81(3):398-401. PubMed ID: 34625404
[TBL] [Abstract][Full Text] [Related]
13. The risk of fracture among patients with psoriatic arthritis and psoriasis: a population-based study.
Ogdie A; Harter L; Shin D; Baker J; Takeshita J; Choi HK; Love TJ; Gelfand JM
Ann Rheum Dis; 2017 May; 76(5):882-885. PubMed ID: 28093419
[TBL] [Abstract][Full Text] [Related]
14. Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis.
Solomon DH; Love TJ; Canning C; Schneeweiss S
Ann Rheum Dis; 2010 Dec; 69(12):2114-7. PubMed ID: 20584807
[TBL] [Abstract][Full Text] [Related]
15. Treatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in Germany.
Lyu R; Govoni M; Ding Q; Black CM; Kachroo S; Fan T; Ogbonnaya A; Donga P; Hill J; Makin C
Rheumatol Int; 2016 Jan; 36(1):143-53. PubMed ID: 26314368
[TBL] [Abstract][Full Text] [Related]
16. Long-term safety of certolizumab pegol in rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, psoriasis and Crohn's disease: a pooled analysis of 11 317 patients across clinical trials.
Curtis JR; Mariette X; Gaujoux-Viala C; Blauvelt A; Kvien TK; Sandborn WJ; Winthrop K; de Longueville M; Huybrechts I; Bykerk VP
RMD Open; 2019; 5(1):e000942. PubMed ID: 31245056
[TBL] [Abstract][Full Text] [Related]
17. Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study.
Wilson FC; Icen M; Crowson CS; McEvoy MT; Gabriel SE; Kremers HM
Arthritis Rheum; 2009 Feb; 61(2):233-9. PubMed ID: 19177544
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and incidence rates of cardiovascular, autoimmune, and other diseases in patients with psoriatic or psoriatic arthritis: a retrospective study using Clinical Practice Research Datalink.
Edson-Heredia E; Zhu B; Lefevre C; Wang M; Barrett A; Bushe CJ; Cox A; Wu JJ; Maeda-Chubachi T
J Eur Acad Dermatol Venereol; 2015 May; 29(5):955-63. PubMed ID: 25352213
[TBL] [Abstract][Full Text] [Related]
19. Quantification of hand muscle volume and composition in patients with rheumatoid arthritis, psoriatic arthritis and psoriasis.
Friedberger A; Figueiredo C; Grimm A; d'Oliveira I; Bäuerle T; Rech J; Kleyer A; Simon D; Uder M; Schett G; Engelke K
BMC Musculoskelet Disord; 2020 Apr; 21(1):203. PubMed ID: 32241261
[TBL] [Abstract][Full Text] [Related]
20. Risk of Subsequent Infection Among Patients Receiving Tumor Necrosis Factor Inhibitors and Other Disease-Modifying Antirheumatic Drugs.
Accortt NA; Bonafede MM; Collier DH; Iles J; Curtis JR
Arthritis Rheumatol; 2016 Jan; 68(1):67-76. PubMed ID: 26359948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
